Most people meet a cannabinoid for the first time on a bottle label, and the label says very little about what happens after the first drop. The body runs its own cannabinoid chemistry, and that is where the story of CBD oil starts. A bit of history, a few receptor names, and a look at the liver explain most of it.
How Scientists Found the System
CBD was first isolated from cannabis in 1940 by the American chemist Roger Adams. Its chemical structure took more than two decades to work out. Raphael Mechoulam and Yuval Shvo solved it in 1963 at the Weizmann Institute in Israel, and Mechoulam’s group followed with THC in 1964. Mechoulam spent more than six decades on cannabinoid chemistry and died in 2023.
The compounds were known long before anyone understood why the body responded to them. That answer arrived in pieces:
- 1988: a team led by Allyn Howlett at St. Louis University School of Medicine found a binding site for THC in rat brain tissue, later named the CB1 receptor
- 1990: the gene for the CB1 receptor was cloned
- 1992: anandamide, a molecule the body makes on its own, was isolated from pig brain and named after the Sanskrit word for bliss
- 1993: a second receptor, CB2, was identified, mostly in immune tissue
- 1995: a second self-made molecule, 2-AG, was identified
Taken together, these findings gave the endocannabinoid system its name. The body produces its own signaling molecules, and compounds from the cannabis plant happen to fit the same locks. Researchers are still mapping the details, and plenty remains unsettled.
Where CBD Acts
Receptors
CB1 receptors sit mostly in the brain and nervous system. CB2 receptors are more common in immune cells and peripheral tissue. THC binds CB1 directly, which accounts for its mind-altering effects. CBD has a low attraction to those same sites. Laboratory work published in 2015 in the British Journal of Pharmacology described CBD as a negative allosteric modulator of CB1, meaning it can change how the receptor responds to other molecules without occupying the main binding spot.
Enzymes and other targets
Anandamide is cleared by an enzyme called FAAH. Lab studies report that CBD can slow that clearance, which leaves more anandamide available. CBD also interacts with the serotonin 5-HT1A receptor, the TRPV1 channel (involved in heat and pain signaling), and an orphan receptor called GPR55. Most of this evidence comes from cell and animal experiments.
Even for the one approved drug, the picture has gaps. The Epidiolex prescribing information states that the exact way it reduces seizures in humans is unknown.
Short version: CBD touches many targets lightly, and no single one explains what people report.
The entourage idea
The phrase “entourage effect” traces back to a 1998 paper by S. Ben-Shabat and Mechoulam, which found that inactive fatty acid compounds boosted the activity of 2-AG in laboratory tests. Neurologist Ethan Russo applied the idea to cannabis in a 2011 review, suggesting that terpenes and minor cannabinoids might shape the effects of the whole plant. It is the reason full spectrum products exist as a category. Controlled human trials comparing full spectrum oils with isolate are scarce, so the idea remains a hypothesis.
What Happens After the Drops
Here is the practical side. A dose of CBD oil moves through a few stages, and each one changes how much reaches the bloodstream.
- Absorption. Oil placed under the tongue is partly absorbed through the lining of the mouth, but a large share gets swallowed. Swallowed CBD is poorly absorbed. A 2018 systematic review in Frontiers in Pharmacology (Millar and colleagues) cites oral bioavailability of about 6 percent on an empty stomach.
- Food. Fat helps. The Epidiolex label reports that a high-fat meal raised peak blood levels roughly fivefold and total exposure about fourfold. Same bottle, same dose, very different result.
- The liver. Enzymes including CYP3A4 and CYP2C19 break CBD down, and one product of that process, 7-OH-CBD, is itself active. Medicines that use the same enzymes can shift the levels of either one. In epilepsy care, CBD raises the blood level of an active byproduct of the seizure drug clobazam, so that drug’s dose sometimes needs adjusting. Case reports also describe higher INR readings (a blood-clotting measure) in people taking warfarin alongside CBD.
- Clearance. With repeated dosing, the Epidiolex label reports a half-life of 56 to 61 hours, so levels can linger for days.
A table pulls the main factors together:
| Factor | Effect on CBD reaching the blood | Example |
|---|---|---|
| High-fat meal | Higher | About 4 to 5 times the exposure in the Epidiolex label |
| Empty stomach | Lower | Oral bioavailability near 6 percent |
| Reduced liver function | Slower clearance | Label calls for lower doses in moderate or severe impairment |
| Other medicines on the same enzymes | Levels of either drug may change | Clobazam, warfarin |
Timing and form
For an oral dose, the Epidiolex label places peak blood levels at roughly 2.5 to 5 hours at steady state. That is a pharmaceutical solution, so retail oils may behave differently, and holding the oil under the tongue changes the early part of the curve. Topical creams and balms are a separate category. They are made to act on the skin, and research on how much CBD passes from a cream into the blood is limited.
Why two people react differently
Body weight, meals, other medicines, liver function, the carrier oil, and plain individual sensitivity all play a part. That explains why one person reports a clear effect from a serving while a friend taking the same serving reports nothing.
A few habits make the picture easier to read. Take the oil at the same time of day and in the same relation to meals. Write down the serving, the time, and what happened. Tell a pharmacist about every product in the cabinet, including supplements, because interactions are far easier to prevent than to untangle.
Final Thoughts
CBD interacts with the body’s signaling system indirectly and through several other targets, and the exact mechanisms are still being worked out. Absorption from an oral dose is low and shifts with food, so consistency matters more than precision. The liver handles CBD with the same enzymes that process many prescription drugs, which makes a pharmacist conversation worthwhile. Plain notes on timing and effects tell a person more than any label can.
Related video: Dr David Allen on the endocannabinoid system and CBD
https://youtu.be/LCs4B-oXOdk
Article 3
CBD Oil for Sleep and Stress
About one in three U.S. adults report sleeping fewer than the recommended seven hours a night, according to the Centers for Disease Control and Prevention. Plenty of them end up searching for a fix late at night, and CBD oil turns up in almost every result. The promises are easy to find. The evidence takes more digging.
The Numbers Behind the Search
Sleep trouble and anxiety are common enough that the interest makes sense. The National Institute of Mental Health estimates that 19.1 percent of U.S. adults had an anxiety disorder in the past year, and 31.1 percent will have one at some point in life. The American Academy of Sleep Medicine and the Sleep Research Society have issued a consensus statement that adults should regularly sleep at least seven hours.
The 2019 Gallup poll on CBD use found anxiety among the leading reasons people gave for taking it, and sleep complaints appeared as well. Demand, in other words, runs well ahead of the research.
A quick snapshot:
- U.S. adults reporting under 7 hours of sleep: about 1 in 3 (CDC)
- U.S. adults with an anxiety disorder in a given year: 19.1 percent (NIMH)
- CBD products approved by the FDA for sleep or anxiety: none
That last line surprises people. The only FDA-approved CBD medicine, Epidiolex, treats certain seizure disorders.
What Studies Have Found
Anxiety
The best-known human work uses public speaking as a stress test. In a 2011 study in Neuropsychopharmacology, a Brazilian team gave people with social anxiety disorder either 600 mg of CBD or a placebo before a simulated speech. The CBD group reported less anxiety and discomfort. A single dose, a small group, and a lab setting limit how far the result travels.
A 2017 study in Frontiers in Pharmacology tested 100, 300, and 900 mg of CBD in 57 healthy men before a public speaking task. Only the 300 mg dose reduced anxiety. Researchers described the pattern as an inverted U: too little did nothing, and too much did nothing either. Dose and response do not climb in a straight line.
Sleep
The most cited sleep paper is a case series from a Colorado psychiatric clinic, published in The Permanente Journal in 2019. It followed 72 adults, 47 with anxiety and 25 with poor sleep, most of whom took 25 mg of CBD daily as a capsule. Anxiety scores fell in about 79 percent of patients during the first month. Sleep scores improved in about 67 percent of patients in that same month, but the numbers moved up and down over time. There was no placebo group, so the results cannot separate CBD from expectation, other treatments, or chance.
A 2017 literature review in Current Psychiatry Reports called the evidence preliminary and asked for larger controlled trials. An older trial from 1981 reported longer sleep time with a 160 mg dose than with placebo, though it was small by modern standards.
The dose problem
Compare those numbers with the shelf. The anxiety studies used 300 to 600 mg in one sitting. A typical retail serving runs about 10 to 25 mg. One 300 mg dose equals twelve servings at 25 mg, and 600 mg equals up to sixty servings at 10 mg. Few studies have tested the amounts people actually buy.
| Claim | What exists | Strength of evidence |
|---|---|---|
| Lowers anxiety in a speaking test | Small placebo-controlled trials at 300 to 600 mg | Limited, single doses in lab settings |
| Improves sleep in people with anxiety | One case series, 72 adults, no placebo | Low |
| Treats chronic insomnia | Very few controlled trials | Low |
| Works at 10 to 25 mg servings | Few studies at these amounts | Unclear |
What Has a Stronger Track Record
Before adding a supplement, it helps to know what the guidelines actually lead with.
- Cognitive behavioral therapy for insomnia (CBT-I). The American College of Physicians’ 2016 guideline recommends CBT-I as the initial treatment for chronic insomnia in adults. It works through sleep scheduling and changing the thoughts that keep a person awake, and it can be delivered by a therapist, a program, or an app.
- A fixed wake time, seven days a week. This anchors the body clock better than any evening routine.
- A caffeine cutoff. A 2013 study in the Journal of Clinical Sleep Medicine found that 400 mg of caffeine taken six hours before bed cut sleep time by more than an hour. That is about two to four cups of coffee, depending on strength.
- Morning light and daytime movement. Both push sleepiness toward the evening.
- A cool, dark, quiet bedroom. Boring, and effective.
If CBD oil is on the table anyway
Plenty of people try it, and a few practical points reduce the downside:
- Drowsiness is among the most commonly reported side effects in Epidiolex trials, and alcohol or sedating medicines can add to it
- A first dose belongs at home, on a night with nothing to drive to in the morning
- Medications and liver conditions change the calculation, so a pharmacist or physician should hear about the plan first
- A product with a batch-specific lab report is a safer bet than one without
- A sleep diary with the serving, time, and next-morning rating shows within two weeks whether anything changed
Persistent trouble sleeping can point to sleep apnea, depression, thyroid problems, or other conditions. A supplement can hide those signals for a while without addressing them.
Final Thoughts
The research on CBD oil for sleep and stress is early, mixed, and based mostly on doses far higher than retail servings. No CBD product has FDA approval for either problem. Habits and CBT-I have much stronger support, and they cost little. Anyone who tries CBD oil should treat it as an experiment with notes, a tested product, and a clinician in the loop.
Related video: